Thyroid cancer is the most common endocrine malignancy and accounts for more than 90% of tumors of the endocrine system. In 2010, it ranked the third most prevalent cancer among Saudi adults, after breast and colorectal cancer  . It ranks the second among females after breast cancer and the twelfth among males in Saudi Arabia. An estimated 697 newly diagnosed thyroid cancer cases were recorded in Saudi Arabia in 2010  .
The incidence of thyroid cancer has increased substantially around the world. In the United States, the overall incidence rose from 1.3/100,000 for women and 4.6/100,000 for men in 1935 to 16.3/100,000 for women and 5.6/100,000 for men in 2008  .
The objective of this study was to determine the prevalence of thyroid cancer among patients who were treated and followed up at King Abdulaziz University Hospital (KAUH), Jeddah, in the western region of Saudi Arabia. It also aims to describe the demographic and clinical characteristics of thyroid cancer patients.
This retrospective cohort study was conducted on patients who underwent thyroid surgery for nodular thyroid disease at KAUH, Jeddah, Saudi Arabia between January 2001 and December 2010. Patients older than 15 years with a proven histopathological diagnosis of thyroid cancer and who had received surgical treatment were included in this analysis. All cases of benign thyroid tumors and other malignancies (such as lymphomas and sarcomas) were excluded.
Patients’ charts were reviewed using their medical record numbers after obtaining ethics committee approval. Medical records were reviewed for age at operation, gender, nationality, family history of thyroid cancer, and clinical presentation. We recorded histopathological findings and radioactive iodine (RAI) treatment (if administered).
Documented also were details of histopathology diagnosis, including the histopathological subtype, size of the tumor, presence of capsular and vascular invasion, extrathyroidal extension, and tumor surgical resection margin status. Lymph node involvement, distant metastasis, and mortality from thyroid malignancy were obtained.
Local recurrence was defined as histopathologically proven malignant thyroid tissue at the thyroid bed or cervical lymph nodes that required surgical resection or a second RAI dose.
Data were analyzed using the Statistical Package for Social Science (SPSS Inc., IBM, US), version 16. Mean ± standard deviation (SD) was calculated for quantitative data and proportions for categorical variables. The unpaired student’s t-test was used to compare the means of continuous variables. Proportions were compared using the chi-square test. A P-value < 0.05 was considered significant throughout the study.
This study included 114 patients aged 40 years on average (range 15 - 87 years; median, 38 years). The majority of cases were females (n = 91; 79.8%), representing a female to male ratio of 4:1. The mean age of the patients categorized by histopathological subtype was 39.6 years for papillary thyroid cancer (PTC), 43.2 years for follicular thyroid cancer (FTC), 55.8 years for medullary thyroid cancer (MTC) and 46.0 years for anaplastic thyroid cancer (ATC). Saudi patients accounted for 57% of the cases (n = 65). Among non-Saudi patients, 38 were Asian (78%) and the remainder African.
The majority of our patients presented with a right thyroid nodule (n = 64; 52%), followed by a left thyroid nodule (n = 42; 34%). The remaining cases were simple diffuse goiter and multinodular goiter (MNG), documented in 11% and 3% of the patients, respectively. Two patients presented with cervical lymphadenopathy, with normal thyroid gland.
A family history of thyroid cancer was documented in eight patients (7%). A history of other malignancies was documented in two patients (1.6%). Both patients were females, one of whom had breast cancer and the other colon cancer.
Total thyroidectomy and near total thyroidectomy were the most common surgical procedures performed in 106 patients (92%). Eight patients (7%) had either a right or left lobe thyroidectomy. Cervical lymph node dissection was performed in 18 patients (15%).
Papillary thyroid carcinoma was diagnosed in 88 cases (77%), followed by FTC, which was diagnosed in 19 cases (17%) Table 1. Table 2 shows the histopathological subtypes of differentiated thyroid cancer. Most of the cases with PTC had tumors <1 cm (n = 25); 17 patients had tumor sizes >4 cm (Table 2). Conversely, patients with FTC, in the majority of cases (n = 9), had tumor size >4 cm; only one patient had a tumor <1 cm. In pa-
Table 1. Frequency of histological types of thyroid carcinoma in the sample*.
*The data are presented as frequency and frequency (percent).
Table 2. Histological characteristic of thyroid carcinoma in the sample.
Abbreviations: DTC, differentiated thyroid carcinoma; FTC, follicular thyroid carcinoma; PTC, papillary thyroid carcinoma.
tients with MTC, tumor size ranged between 2.1 and 4 cm and greater, whereas patients with anaplastic thyroid carcinoma (ATC) had tumors >4 cm in diameter.
Extrathyroidal extension to surrounding muscle and fat tissue was documented in 15 cases of PTC (16%), 1 case of FTC (4.5%), and all cases of ATC (100%). Lymph node metastasis was confirmed in 25 cases of PTC (27%), 1 case of FTC (4.5%), 2 cases of MTC (40%), and all cases of ATC (100%). Local recurrence at the thyroid bed or cervical lymph node was documented in 10 cases of PTC (11%), 1 case of FTC (4.5%), and none of the other tumor variants (Table 3).
Distant metastasis was documented in 14 cases of PTC (15%). Of these, seven patients had liver metastasis, four had lung metastasis, two had multiple-organ metastasis (liver, brain, and lung), and one had mediastinal metastasis. On the contrary, in patients with FTC, only two cases (9%) had distant metastasis (one case to the liver and the other to the lung). Distant metastasis was documented in two patients with MTC (40%), whereas neither of the two patients with ATC had metastatic disease.
Two patients with PTC died, which yielded a mortality rate of 1.6%. One patient died from uncontrolled carotid bleeding due to thyroid infiltration by malignant cells. The other died from massive hemoptysis and respiratory distress caused by metastatic invasion of the trachea.
Further analysis demonstrated a mild significant association between PTC and younger age (P = 0.09). In addition, patients with PTC were more likely to have distant metastasis (P = 0.006).
In our study, 80% of patients with thyroid cancer were female. The median age of patients in our study was 38 years, similar to that of patients documented in the Saudi cancer registry (47 years among males and 38 years among females) for the year 2010  . In a study conducted at King Faisal Specialist Hospital and Research Center (KFSH & RC), from 2000 to 2010, thyroid cancer patients comprised 76.3% females and 23.7% males  .
Table 3. Staging of thyroid carcinoma in the sample.
Abbreviations: ATC, anaplastic thyroid carcinoma; DTC, differentiated thyroid carcinoma; FTC, follicular thyroid carcinoma; MTC, medullary thyroid carcinoma; PTC, papillary thyroid carcinoma.
In our study, most of the patients presented with right thyroid nodules, followed by left thyroid nodule. Papillary thyroid cancer comprised about 85% of cases compared with about 12% of FTC cases in a study conducted in the United States  . In our study, PTC was the most frequently diagnosed thyroid cancer and accounted for 77% of all thyroid cancer cases at KAUH. This is similar to national and international figures. A previous study conducted at KAUH in 2002 showed that PTC was the most common type of thyroid cancer (82%). Another study from the central region of Saudi Arabia reported PTC in 89% of thyroid cancer cases   . In the eastern province, some investigators reported papillary thyroid cancer in 74% of their cohort  . Another study at KFSH & RC revealed that papillary adenocarcinomas accounted for 72% of all thyroid cancers  , whereas other investigators at the same institution found that 83.3% of their patients had PTC  .
Follicular thyroid cancer accounted for 17% of the sample in our study. This frequency is higher than that reported in other studies conducted in Saudi Arabia. Alamoudi et al.  found that FTC accounted for 3.7% of all thyroid cancers diagnosed between January 2000 and September 2006 at KFSH & RC.
In the current study, MTC accounted for 4% of thyroid cancers, similar to the rate reported in studies conducted abroad  . In a study at KFSH & RC, Jeddah, Saudi Arabia, 4.6% of thyroid cancers were MTC  .
This study has all the limitations inherent to retrospective chart reviews. In addition, data were missing in the electronic health records because some patients were referral cases from other hospitals or cities. As a result, we had to collect data from the hospital archives.
Overall, thyroid cancer is more common in females, with a female to male ratio of 4:1. Patients in our setting tend to present with thyroid cancer at a young age (40 years on average). Most patients present with neck lumps and PTC is the most common histopathological variant.
 Hussain, F., Iqbal, S., Mehmood, A., Bazarbashi, S., El-Hassan, T. and Chaudhri, N. (2013) Incidence of Thyroid Cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematology/Oncology and Stem Cell Therapy, 6, 58-64. http://dx.doi.org/10.1016/j.hemonc.2013.05.004
 Hundahl, S.A., Cady, B., Cunningham, M.P., Mazzaferri, E., McKee, R.F., Rosai, J., Shah, J.P., Fremgen, A.M., Stewart, A.K. and H?lzer, S. (2000) Initial Results from a Prospective Cohort Study of 5583 Cases of Thyroid Carcinoma Treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer, 89, 202-217. http://dx.doi.org/10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A
 Al-Amri, A.M. (2012) Pattern of Thyroid Cancer in the Eastern Province of Saudi Arabia: University Hospital Experience. Journal of Cancer Therapy, 3, 187-191. http://dx.doi.org/10.4236/jct.2012.33027
 Alamoudi, O., Hamour, O.A., Mudawi, I., Khayyat, A., Batwail, N. and Elhadd, T.A. (2011) Consensus Based Management of Differentiated Thyroid Cancer in Tertiary Care Set-Up. International Journal of Surgery, 9, 96-100. http://dx.doi.org/10.1016/j.ijsu.2010.10.005